Inner ear organoids: From three-dimensional bioprinting to vascularization
Fuzheng Li , Kexin Yang , Mohsen Asadnia , Jianxia Chen , Guozhen Liu
Organoid Research ›› 2026, Vol. 2 ›› Issue (1) : 025010041
The inner ear is essential for auditory perception and balance, yet damage to cochlear hair cells remains a major cause of irreversible hearing loss worldwide. As the number of individuals affected by sensorineural deafness continues to rise, there is a growing need for deeper pathophysiological insight and the development of effective therapies. Inner ear organoids, which recapitulate key aspects of the in vivo inner ear microenvironment, have emerged as powerful platforms for disease modeling, high-throughput drug screening, and regenerative medicine. This review summarizes recent progress in the development of inner ear organoids, with a focus on strategies to improve their structural complexity and functional maturity. In particular, we highlight innovations in vascularization and three-dimensional bioprinting that are advancing organoid scalability and integration potential. Meanwhile, commonly used biomaterials in three-dimensional bioprinting for inner ear organoids are systematically compared. Finally, we discuss current challenges and future directions for translating these technologies into clinical applications.
Inner ear / Organoids / Vascularization / Three-dimensional bioprinting / Biomaterials / Hair cell regeneration
| [1] |
|
| [2] |
|
| [3] |
World Health Organization. Deafness and hearing loss. Available from: https://www.who.int/news-room/fact- sheets/detail/deafness-and-hearing-loss [Last accessed on August 6, 2025]. |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
/
| 〈 |
|
〉 |